gene

Bluebird’s $2.8 million gene therapy becomes most expensive drug after U.S. approval

By Mrinalika Roy (Reuters) -The U.S. Meals and Drug Administration on Wednesday authorized bluebird bio’s gene remedy for sufferers with…